Compare MBRX & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MBRX | PETZ |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 10.9M |
| IPO Year | 2016 | 2017 |
| Metric | MBRX | PETZ |
|---|---|---|
| Price | $4.56 | $1.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $105.50 | N/A |
| AVG Volume (30 Days) | ★ 163.3K | 15.6K |
| Earning Date | 03-20-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $1,046,006.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.32 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.13 | $0.65 |
| 52 Week High | $91.25 | $1.68 |
| Indicator | MBRX | PETZ |
|---|---|---|
| Relative Strength Index (RSI) | 58.19 | 59.91 |
| Support Level | $4.26 | $1.04 |
| Resistance Level | $5.15 | $1.20 |
| Average True Range (ATR) | 0.37 | 0.08 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 56.47 | 65.04 |
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.